OSLO, Norway, June 7, 2016 -- Norwegian aluminium company Norsk Hydro ASA's fully owned subsidiary, Hydro Aluminium AS, has entered into a sales agreement with Sapa AS, a global provider of downstream aluminium solutions, owned 50 percent by Hydro, to supply extrusion ingot under an open-ended agreement starting in 2017.
The agreement covers extrusion ingot in Europe, and replaces the existing contract, which was entered into at the closing of the Sapa Joint venture in 2013, and expires by the end of 2016. The agreement is at market terms, and covers a volume commitment range of 250 to 300 kmt, that can be adjusted on a yearly basis.
"Hydro's experience and technological edge along the value chain provides our customers with value added aluminium products, and we are happy to continue our supply of high quality aluminium to Sapa," says President and CEO, Svein Richard Brandtzæg.
Sapa is the world leader in downstream aluminium solutions - a result of the merger of the aluminium extrusion businesses of Orkla and Hydro. Sapa has a global reach and local presence within extrusions, building systems, and precision tubing. Sapa has 22,800 employees in more than 40 countries, and the headquarters are located in Oslo, Norway.
Investor contact
Contact Stian Hasle
Cellular +47 97736022
E-mail [email protected]
Press contact
Contact Halvor Molland
Cellular +47 92979797
E-mail [email protected]
HUG#2018369


Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Italy Fines Apple €98.6 Million Over App Store Dominance
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 



